Document Detail


Differences in vascular effects and removal of endothelin-1 in human lung, brain, and skeletal muscle.
MedLine Citation:
PMID:  8119059     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
To investigate the effects and elimination of endothelin-1 in humans, an intravenous infusion of endothelin-1 (ET-1) (4 pmol kg-1 min-1 for 20 min) was given to 10 healthy volunteers. Arterial plasma endothelin-1 like immunoreactivity (ET-1-LI) increased eleven-fold. The fractional extraction of ET-1-LI was 41% and 30% across the pulmonary and skeletal muscle vascular beds, respectively. The lung eliminated almost half of the administered ET-1. No fractional extraction was found in the cerebral circulation. The pulmonary oxygen uptake (VO2) was increased slightly by endothelin-1. Across both the cerebral and skeletal muscle vascular beds the arterio-venous oxygen difference decreased (P < 0.05), suggesting vasodilation, the effect lasting up to 1 h after the end of endothelin-1 infusion in the cerebral circulation. Arterial-pulmonary artery oxygen difference increased by 20%. ET-1 infusion led to a decrease in heart rate (10%), cardiac output (14%) and stroke volume (8%) (all with P < 0.05) as well as a 7% increase in mean arterial blood pressure. Pulmonary and systemic vascular resistance increased by 67% and 25%, respectively (P < 0.05). These results demonstrate the regional differences in the removal of circulating endothelin-1, the lung being mainly responsible for the plasma elimination. Endothelin-1 seems to exert both vasoconstrictive and vasodilatory actions in humans, probably depending on differences in receptor populations and endothelium configuration in various vascular beds.
Authors:
E Weitzberg; G Ahlborg; J M Lundberg
Related Documents :
1124859 - Isoproterenol aerosols.
18603749 - Treatment of ethanol-induced acute pulmonary hypertension and right ventricular dysfunc...
2438759 - Correlation of nyha classification, bicycle ergometry and right heart haemodynamics aft...
3751929 - Effects of ci-914 in congestive heart failure due to coronary artery disease or idiopat...
6491069 - Noninvasive estimation of peak pulmonary artery pressure by m-mode echocardiography.
7685249 - Influence of a pentoxifylline-analogue on the granulocyte-mediated pulmonary mediator r...
10981559 - Candesartan cilexetil and renal hemodynamics in hypertensive patients.
6216839 - Effect of continuous positive airway pressure on respiratory mechanics and pattern of b...
20528389 - Pharmacoeconomics and quality of life analysis of telmisartan in hypertension treatment.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical physiology (Oxford, England)     Volume:  13     ISSN:  0144-5979     ISO Abbreviation:  Clin Physiol     Publication Date:  1993 Nov 
Date Detail:
Created Date:  1994-04-06     Completed Date:  1994-04-06     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8309768     Medline TA:  Clin Physiol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  653-62     Citation Subset:  IM    
Affiliation:
Department of Anaesthesiology and Intensive Care, Karolinska Hospital, Stockholm, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Brain / metabolism*
Cardiac Output / drug effects
Cerebrovascular Circulation / drug effects*
Endothelins / metabolism,  pharmacology*
Hemodynamics / drug effects
Humans
Infusions, Intravenous
Lung / metabolism*
Male
Muscles / blood supply*,  metabolism
Oxygen / blood
Pulmonary Circulation / drug effects*
Radioimmunoassay
Regional Blood Flow / drug effects
Vascular Resistance / drug effects
Chemical
Reg. No./Substance:
0/Endothelins; 7782-44-7/Oxygen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The effect of hyperosmotic solutions on the hepatic blood flow.
Next Document:  Spontaneous baroreflex by sequence and power spectral methods in humans.